Company news
Panbela Therapeutics, Inc. news in 2016
Panbela Therapeutics, Inc.'s news releases, calls and decks from 2016, newest first.
Sun BioPharma to Initiate Fifth Patient Cohort in its Dose Escalation Phase 1 Study of SBP-101 for Pancreatic Cancer
December 7, 2016
Sun BioPharma Reports Third Quarter 2016 Results and Provides Clinical Progress Update
November 10, 2016
Sun BioPharma, Inc. to Present at the Innovation Biotech Showcase on October 26th
October 24, 2016
Sun BioPharma Receives DSMB Approval to Start Fourth Patient Cohort in the Dose Escalation Phase 1 Study of SBP-101 for Pancreatic Cancer
October 6, 2016
Sun BioPharma Announces Effectiveness of its Registration Statement on Form S-1
October 3, 2016